Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis T Malagón, M Drolet, MC Boily, EL Franco, M Jit, J Brisson, M Brisson The Lancet infectious diseases 12 (10), 781-789, 2012 | 548 | 2012 |
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis N Van de Velde, MC Boily, M Drolet, EL Franco, MH Mayrand, EV Kliewer, ... Journal of the National Cancer Institute 104 (22), 1712-1723, 2012 | 172 | 2012 |
Health and economic impact of switching from a 4-valent to a 9-valent HPV vaccination program in the United States M Brisson, JF Laprise, HW Chesson, M Drolet, T Malagón, MC Boily, ... Journal of the National Cancer Institute 108 (1), djv282, 2016 | 103 | 2016 |
Comparing the cost-effectiveness of two-and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study JF Laprise, M Drolet, MC Boily, M Jit, C Sauvageau, EL Franco, ... Vaccine 32 (44), 5845-5853, 2014 | 85 | 2014 |
Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada T Malagón, JHE Yong, P Tope, WH Miller Jr, EL Franco, ... International journal of cancer 150 (8), 1244-1254, 2022 | 68 | 2022 |
Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated women: a modelling study T Malagón, S Kulasingam, MH Mayrand, G Ogilvie, L Smith, C Bouchard, ... The lancet oncology 19 (12), 1569-1578, 2018 | 56 | 2018 |
McGill Task Force on the Impact of COVID-19 on Cancer Control and Care. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada T Malagón, JHE Yong, P Tope, WH Miller Jr, EL Franco Int. J. Cancer 150 (8), 1244-1254, 2022 | 47 | 2022 |
Inequalities in human papillomavirus (HPV)–associated cancers: implications for the success of HPV vaccination M Brisson, M Drolet, T Malagón Journal of the National Cancer Institute 105 (3), 158-161, 2013 | 34 | 2013 |
Estimating HPV DNA deposition between sexual partners using HPV concordance, Y chromosome DNA detection, and self-reported sexual behaviors T Malagón, AN Burchell, M El-Zein, J Guénoun, PP Tellier, F Coutlée, ... The Journal of infectious diseases 216 (10), 1210-1218, 2017 | 31 | 2017 |
Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study T Malagón, K Louvanto, M Wissing, AN Burchell, PP Tellier, M El-Zein, ... The Lancet Infectious Diseases 19 (3), 317-326, 2019 | 30 | 2019 |
Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review T Malagón, C Laurie, EL Franco Expert review of vaccines 17 (5), 395-409, 2018 | 27 | 2018 |
The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis T Malagón, V Joumier, MC Boily, N Van de Velde, M Drolet, M Brisson Vaccine 31 (13), 1740-1747, 2013 | 23 | 2013 |
Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: systematic review and meta‐analysis T Malagon, KD Volesky, S Bouten, C Laprise, M El‐Zein, EL Franco International Journal of Cancer 147 (10), 2695-2707, 2020 | 21 | 2020 |
Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era T Malagón, M Drolet, MC Boily, JF Laprise, M Brisson Cancer epidemiology, biomarkers & prevention 24 (1), 276-285, 2015 | 20 | 2015 |
Bias due to correlation between times-at-risk for infection in epidemiologic studies measuring biological interactions between sexually transmitted infections: a case study … T Malagón, P Lemieux-Mellouki, JF Laprise, M Brisson American Journal of Epidemiology 184 (12), 873-883, 2016 | 19 | 2016 |
Sex-and type-specific genital human papillomavirus transmission rates between heterosexual partners: a Bayesian reanalysis of the HITCH cohort T Malagón, A MacCosham, AN Burchell, M El-Zein, PP Tellier, F Coutlée, ... Epidemiology 32 (3), 368-377, 2021 | 14 | 2021 |
Modeling cervical cancer screening strategies with varying levels of human papillomavirus vaccination DR Grimes, EMA Corry, T Malagón, C O’Riain, EL Franco, DJ Brennan JAMA network open 4 (6), e2115321-e2115321, 2021 | 13 | 2021 |
Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age T Malagón, K Louvanto, AV Ramanakumar, A Koushik, F Coutlée, ... Gynecologic Oncology 155 (2), 245-253, 2019 | 13 | 2019 |
Assortativity and mixing by sexual behaviors and sociodemographic characteristics in young adult heterosexual dating partnerships T Malagón, A Burchell, M El-Zein, PP Tellier, F Coutlée, EL Franco, ... Sexually transmitted diseases 44 (6), 329-337, 2017 | 11 | 2017 |
Proportion of incident genital human papillomavirus detections not attributable to transmission and potentially attributable to latent infections: implications for cervical … T Malagón, A MacCosham, AN Burchell, M El-Zein, PP Tellier, F Coutlée, ... Clinical Infectious Diseases 75 (3), 365-371, 2022 | 10 | 2022 |